Every three years, the International Symposium on Pheochromocytoma hosts hundreds of clinician scientists dedicated to researching this rare cancer at the International Symposium on Pheochromocytoma. This year’s event, hosted in Montreal by CHUM Hospital, focused on the latest discoveries and perspectives in the field, providing much-needed hope for patients. Pheo Para Alliance sponsored the ISP to support the sharing of research worldwide. Stephanie Alband, PPA’s Executive Director, was invited to present on the Pheo Para Center of Excellence program. In addition, Miranda Edwards, aka Pheo vs. Fabulous, spoke representing the patient voice. Although this is a research symposium geared towards clinician scientists, patients were welcome to attend. PPA also held a free patient education day on Saturday, September 20 at CHUM.
More About ISP
From its 2005 inception at the National Institutes of Health in Bethesda, Maryland, USA, the International Symposium on Pheochromocytoma has gathered internationally prominent clinicians and scientists in order to foster cross-continental partnerships. Under the auspices of the Pheochromocytoma and Research and Support Organization (PRESSOR), worldwide experts have convened every three years in Cambridge, England, Paris, France, Kyoto, Japan, and Sydney, Australia to present, discuss, and explore therapeutic options, novel genetic and metabolomic approaches, diagnostic imaging, translational research efforts and much more.
Plenary sessions focus on the latest discoveries and perspectives in genetics and epigenetics, biochemistry and metabologenomics, theranostics, and mitochondrial function. The symposium welcomed patients and will have several sessions devoted to patient management, including unique case presentations and in-person discussions with expert physicians on their approach to the workup, diagnosis, and treatment of patients with this tumor. All health care professionals, scientists, students, patients, and allies are welcome to attend this Symposium, which outline new focuses and avenues for early diagnosis, treatment, and ultimately prevention of pheochromocytoma. Only through spreading the word “pheochromocytoma” can we beat this tumor.
